Pharmaceuticals, Biotechnology and Life Sciences
SBTI ID
40001840
Localisation
Germany
Europe
Secteur d'activité
Pharmaceuticals, Biotechnology and Life Sciences
Type d'organisation
Corporate
Dernière mise à jour
24/10/2024
Statut
Classification
1.5°C
Année cible
2030
Energy & Industry: DFE Pharma GmbH & Co. KG commits to reduce absolute scope 1 and 2 GHG emissions 42% by 2030 from a 2021 base year.* DFE Pharma GmbH & Co. KG also commits to reduce absolute scope 3 GHG emissions from purchased goods and services, upstream transportation and distribution, and end-of-life treatment of sold products 25% within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstocks. FLAG: DFE Pharma GmbH & Co. KG commits to reduce absolute scope 3 FLAG GHG emissions 30.3% by 2030 from a 2021 base year.** DFE Pharma GmbH & Co. KG commits to no deforestation across its primary deforestation-linked commodities, with a target date of December 31, 2025. **The target includes FLAG emissions and removals.
The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C
LEI
529900D9W4X9OOSME741
Source : Science Based Targets initiative | Données publiques